Nestlé S.A.: A Narrow RIG Recovery Behind a 15-16x Operating Multiple Once L'Oréal's CHF 35bn Is Stripped Out, and CHF 78.31 Leaves No Conservative Margin of Safety

H1 2026 also contained a large divergence between operating performance and accounting profit. Sales fell 2.5% on a reported basis to CHF 43.1 billion even as organic growth reached 3.6%, because foreign exchange alone reduced reported sales by 6.2%. UTOP was CHF 7.08 billion and the UTOP margin 16.4%, almost flat year on year. Net profit attributable to shareholders, however, fell 31.4% to CHF 3.47 billion. The difference was primarily restructuring and impairments, including CHF 469 million of restructuring costs, CHF 180 million of PP&E/intangible impairment within trading items and a CHF 1.356 billion loss/write-down related to businesses held for sale.

Those charges are more than accounting noise. The large held-for-sale write-down principally reflects the decision to dispose of mainstream and value vitamins, minerals and supplements. On September 1, Nestlé agreed to sell that business to Yellow Wood Partners for USD 1.0 billion, approximately CHF 0.8 billion; the assets being sold generated about CHF 1.0 billion of 2025 sales. Nestlé had paid USD 5.75 billion in 2021 for the core brands of The Bountiful Company, although the original purchase and today's disposal scopes are not identical because Nestlé retains premium science-led brands such as Solgar and Pure Encapsulations. The comparison cannot be made dollar-for-dollar, but the CHF 1.3 billion write-down and low disposal value are strong evidence that the 2021 capital allocation was poor.

The Waters transaction is different. Nestlé and Platinum Equity intend to form a 50:50 venture, Peranel, covering more than 30 brands including S.Pellegrino, Perrier, Acqua Panna and Pure Life. The announced enterprise value is €4.9 billion, about CHF 4.5 billion, with approximately €3.0 billion/CHF 2.8 billion of cash proceeds expected for Nestlé at closing. Closing is targeted for H1 2027. Until then, the transaction is signed/announced, not completed, and no sale proceeds have been received. Based simply on H1 2026, deconsolidation will remove roughly CHF 3.6 billion of annualized sales and CHF 0.34 billion of annualized UTOP from Nestlé's consolidated statements before considering the retained 50% equity-accounted interest.

Balance-sheet pressure is one reason those proceeds matter. Nestlé's own leverage measure is net debt to adjusted EBITDA, rather than net debt to operating profit: it was 2.90 times at the end of 2024, close to the upper end of the company's two-to-three-times target range. Net debt fell to CHF 51.4 billion at December 2025 but was CHF 56.3 billion at June 2026 because the first half includes the annual dividend and normal seasonality. Management's stated direction is back toward the 2.5-times midpoint. Nestlé simultaneously finished a CHF 20 billion buyback program in December 2024 and did not start another one in 2025, a sensible change in capital allocation once leverage had moved near the top of the range.

For 2026, the guidance in force at the research date is 3–4% organic sales growth, with RIG accelerating from 2025; UTOP margin is expected to improve from the 16.1% achieved in 2025, with H2 margin broadly similar to H1; free cash flow is guided above CHF 9 billion. At July spot rates, management estimated about a 3% full-year FX drag to reported sales. The distinction matters: 3–4% organic growth does not mean 3–4% reported CHF growth.

Qualitatively, this is a company in transition. Nestlé still owns brands with exceptional shelf presence, repeat-purchase behavior and global distribution; its coffee and PetCare economics prove that the moat is more than marketing. Yet the corporate system around those brands spent several years allowing market-share slippage, underinvestment and questionable capital allocation to coexist with an expensive defensive valuation. The current reset is producing better RIG and faster portfolio decisions. The unresolved disagreement is whether H1 2026 is the beginning of a durable return toward 4%+ organic growth and 17%+ margins, or merely a cost-supported stabilization whose best volume numbers are concentrated in emerging markets while Europe, China and portions of North America remain sluggish.

Vertical history, financial evolution and capital-market narrative

Nestlé began from two answers to the same nineteenth-century problem: preserving milk and feeding infants safely in rapidly urbanizing Europe. The Anglo-Swiss Condensed Milk Company was founded in 1866 by the Page brothers and opened Europe's first condensed-milk factory. Henri Nestlé, a trained pharmacist who had moved to Vevey, developed his Farine Lactée infant cereal in 1867. These businesses became direct competitors before merging in 1905. The logic that still defines Nestlé was already present: food technology increased shelf life and consistency, branding created trust in products whose quality consumers could not easily verify themselves, and industrial manufacturing moved those products farther than a local dairy or kitchen could.

Nestlé's listing history predates the modern IPO system. Anglo-Swiss shares were first quoted on the Zurich Stock Exchange on March 17, 1873. Following the 1905 merger, Nestlé & Anglo-Swiss Condensed Milk Co. shares were listed in Zurich on October 25, 1905. Nestlé's own investor archive does not provide a modern prospectus-equivalent IPO price, capital-raised figure or first-day valuation for those nineteenth- and early-twentieth-century quotations; assigning a present-day IPO narrative to the listing would manufacture precision the historical record does not support.

The first lasting expansion carried Nestlé from milk preservation into a broader branded pantry. Nescafé, launched in 1938, converted coffee into an industrially scalable, long-lived product. Maggi joined Nestlé in 1947, widening the company into cooking aids and prepared foods. This phase created a pattern Nestlé would repeat for decades: take a branded product with repeat purchase, apply manufacturing and distribution scale, then move it across countries rather than depend on a single national category.

Premiumization was the second decisive phase. Nespresso, created in 1986, changed coffee economics by linking a proprietary machine system to portioned capsules. Nescafé remained mass-market and globally distributed; Nespresso added premium positioning, direct customer relationships and recurring capsule purchases. That combination explains why coffee now behaves less like an ordinary packaged-food category inside Nestlé. In H1 2026, coffee produced 7.5% organic growth, 2.9% RIG and 4.7% pricing, with category-level UTOP around 19% of sales before unallocated costs.

Phase three was large-scale category acquisition. Ralston Purina is the best example. Nestlé announced the deal in January 2001 and completed it in December for an enterprise value of USD 10.3 billion. Ralston was strong in dry dog food while Nestlé's Friskies was stronger in wet cat food, making the asset combination complementary by product, geography and channel. The deal created a roughly USD 6.3 billion pet-care business at the time. Twenty-five years later, H1 2026 PetCare sales alone were CHF 8.9 billion and category UTOP approximately CHF 1.94 billion, a 21.8% margin. The longevity, margin and global scale now visible in Purina make the Ralston transaction one of the clearest examples of value-creating Nestlé M&A.

Health and supplements went the other way. Nestlé spent USD 5.75 billion in 2021 to buy the core brands of The Bountiful Company as part of an attempt to build Nestlé Health Science into a large nutrition-and-health platform. The thesis looked plausible at the category level: supplements offered premium pricing and a structural wellness narrative. Execution was much worse. Manufacturing and supply problems later constrained VMS sales, and by 2026 Nestlé had decided that mainstream/value brands did not belong in the focused portfolio. The September 2026 agreement to sell those assets for about CHF 0.8 billion, alongside a CHF 1.3 billion held-for-sale write-down, is a reminder that attractive category narratives do not rescue a bad acquisition price or weak integration.

A fourth phase began under Mark Schneider and became more financially assertive: portfolio rotation, substantial disposals, acquisitions in health science, and large shareholder returns. By 2022–24, however, the same capital structure became less forgiving. Nestlé repurchased 187.4 million shares under the CHF 20 billion program begun in January 2022, including CHF 4.4 billion of purchases in 2024. At the end of 2024 net debt had risen to CHF 56.0 billion and net debt/adjusted EBITDA to 2.90 times. Buying back stock while leverage moved to the upper edge of the target range left the next management team less balance-sheet freedom just as growth weakened.

Operational performance was weakening underneath the financial engineering. Organic growth in 2024 was only 2.2%, comprising 0.8% RIG and 1.5% pricing. Nestlé acknowledged that it gained or held share in only about half its business cells by number and in less than half by sales value; 18 underperforming cells representing roughly 21% of group sales accounted for most of the market-share problem. Advertising and marketing expenditure had fallen from 9.0% of sales in 2019 to 6.6% in H2 2022 before recovering to 8.1% in 2024. That underinvestment is one of the strongest explanations for why an apparently wide brand moat stopped translating into adequate organic growth.

Laurent Freixe's 2024 appointment and subsequent September 2025 dismissal should be read against that background. The performance reset did not begin with Navratil. Under Freixe, Nestlé had already introduced action plans for the 18 underperformers, stepped up advertising, reorganized Waters as a standalone global business and launched Fuel for Growth. The board initially said explicitly that Navratil's appointment did not change the strategic course. What changed later was the pace, the willingness to attach headcount to the savings, and the readiness to remove portfolio assets rather than merely improve them.

Chairman succession adds a second layer. Bulcke initially planned to remain until the April 16, 2026 AGM, when Pablo Isla was to be proposed as chairman. After Freixe's dismissal, Bulcke advanced his departure and Isla took over on October 1, 2025. Isla brought an unusually relevant record from outside packaged food: he was CEO of Inditex from 2005 to 2011 and chairman and CEO from 2011 to 2022, and had already sat on Nestlé's board since 2018. In February and April 2026, Nestlé described additional board meetings, altered committee responsibilities and governance changes intended to strengthen oversight.

That does not yet prove better governance. It proves that oversight cadence changed after a failure serious enough to remove a CEO immediately. Management credibility has to be rebuilt through delivery, not inferred from board biographies.

The financial vertical makes the problem visible:

The 2023 RIG/pricing mix is the critical starting point: organic growth was high because pricing was about 7.5% while RIG was slightly negative. By 2024 pricing had normalized, revealing weak underlying volume. In 2025 organic growth improved to 3.5%, but RIG remained only 0.8% for the year; the improvement arrived principally in the second half. H1 2026 is the first period where both the direction of RIG and the investment program make a reasonably coherent turnaround case.

Cash generation is still one of Nestlé's better attributes. My reconstruction of the 2021–25 consolidated cash-flow statements produces cumulative operating cash flow of roughly CHF 73 billion versus cumulative attributable accounting profit of roughly CHF 57 billion, or around 1.3 times. That aggregate needs interpretation: 2021 net profit was unusually affected by the sale of L'Oréal shares, whereas subsequent cash flow reflects working-capital swings and restructuring payments. The five-year evidence is consistent with a genuine cash-generating consumer business rather than an accounting-earnings story. Nestlé's published archive contains the annual cash-flow statements for each year; 2024 FCF was CHF 10.7 billion and 2025 FCF CHF 9.2 billion.

Nestlé's balance sheet is sound but no longer pristine enough to ignore. The company distributed CHF 7.8 billion in dividends and spent CHF 4.4 billion on buybacks during 2024 while net debt climbed CHF 6.4 billion. That moved leverage to 2.90 times adjusted EBITDA. The main capital-allocation priority now should be keeping the dividend sustainable, completing portfolio actions without sacrificing value and returning leverage toward roughly 2.5 times before another large buyback.

Free cash flow also explains why the dividend yield alone cannot be treated as a value signal. The CHF 3.10 dividend approved for 2025 earnings gives a gross yield of about 4.0% at CHF 78.31. It is covered by current FCF, but roughly CHF 8 billion of annual cash distribution leaves less room to deleverage after restructuring, acquisitions and capital investment. A defensive yield is valuable only while the operating franchises continue to support it.

The share-price narrative has followed the operational one. By September 2025 Nestlé had already suffered a prolonged de-rating, and the Freixe dismissal produced a surprisingly muted immediate market response: shares closed 0.7% lower on September 2 despite the governance shock, suggesting investors treated Navratil's internal succession as continuity rather than a strategic break.

October 16, 2025 brought the genuine re-rating event. Nestlé reported Q3 organic growth of 4.3% and RIG of 1.5%, raised the cost-saving ambition to CHF 3 billion, and announced approximately 16,000 job cuts. The shares jumped more than 8% in early trading, with contemporary reporting describing the move as the largest one-day gain since 2008. That reaction says something important about what the market was buying: evidence of volume improvement plus a harder cost regime, rather than the mere fact of new management.

Optimism then met a valuation ceiling. The shares reached a 52-week low of CHF 70.29 on January 26, 2026, recovered to close at CHF 81.43 after the February 19 full-year results, and reached CHF 87.09 on July 22. H1 results on July 23 reversed much of that enthusiasm: the stock was down 6.2% to roughly CHF 80.8 in early Zurich trading as investors absorbed the 31% net-profit decline, restructuring/write-down burden and portfolio actions. By August 25 it closed at CHF 81.21; after the VMS disposal announcement on September 1, the September 4 close was CHF 78.31.

Accelerating the chairman transition did not generate a separately identifiable re-rating of comparable magnitude. Nor does the L'Oréal stake explain the major Nestlé inflections. At the September 4 FX rate, every €10 move in L'Oréal changes the gross mark-to-market value of Nestlé's holding by approximately CHF 1.01 billion, or CHF 0.39 per Nestlé share. L'Oréal matters greatly to intrinsic value, but an 8% one-day Nestlé move requires a far larger operating or multiple shift than normal movement in the associate.

Nestlé's historical valuation center has correspondingly moved down. At CHF 78.31, Nestlé trades at about 22.3 times 2025 reported EPS of CHF 3.51, but that reported P/E is distorted by exceptional charges and, more fundamentally, by the L'Oréal associate. After removing my discounted L'Oréal value from equity and adding current net debt, the market is valuing Nestlé's consolidated operating business at roughly CHF 223 billion enterprise value. Against a roughly CHF 14.5 billion normalized 2026 UTOP, that is around 15–16 times operating profit. As a starting valuation that is far more useful than the headline group P/E.

Business model, moat, industry and horizontal peers

Nestlé's business model looks broad from the outside but its economics are concentrated. H1 2026 category reporting makes that clear:

† Category profit figures precede roughly CHF 1.1 billion of unallocated group costs; they should not be summed as if they were standalone group margins. Waters, excluded from the four-column table to keep it narrow, generated CHF 1.78 billion of H1 sales and a 9.5% UTOP margin.

Branded repeat purchase combined with manufacturing and distribution scale is the real profit machine. A can of Nescafé, Purina wet cat food, infant formula or KitKat is physically inexpensive relative to the consumer selling price, but the gross spread must pay for commodity input costs, factories, logistics, advertising, trade promotions, regulatory compliance and continuous product renovation. Scale matters because Nestlé can spread those costs across dozens of countries and negotiate raw-material procurement, retailer access and digital media at a size few pure-play competitors can match. The H1 gross margin of 46.4%, despite elevated coffee and cocoa costs, shows the economics available before brand investment and overhead.

Brand trust married to distribution is the first real moat. Food brands do not have technological switching costs, and consumers can change chocolate or coffee tomorrow. What protects Nestlé is habitual repeat purchase plus availability. Nescafé, Nespresso, Purina, Maggi and KitKat reach consumers through supermarkets, convenience, out-of-home, direct-to-consumer and e-commerce. E-commerce alone reached more than 20% of group sales by 2025 and continued growing much faster than group sales. A brand that consumers know but cannot find has little value; a distribution network filled with weak brands also has little value. Nestlé owns both layers.

The second moat is category-specific rather than group-wide. Coffee combines sourcing scale, processing knowledge and a portfolio spanning inexpensive soluble coffee through premium systems. Nespresso adds machine/capsule economics and a direct relationship with users; the Starbucks global coffee alliance gives Nestlé another premium brand in packaged at-home coffee. Coffee could therefore take almost 5% H1 pricing while still delivering positive RIG. Cocoa pricing has produced greater volume elasticity in confectionery, which is evidence that “Nestlé brand power” should never be treated as one homogeneous property.

Purina supplies the third moat: nutrition credibility plus pet-owner stickiness. Premium and therapeutic pet food is a category in which owners are less inclined to change products casually when an animal tolerates a diet well. Purina also benefits from the Ralston acquisition's twenty-five years of accumulated distribution and product development. PetCare carried the highest H1 category margin of the major businesses and returned to RIG-led growth in 2025 despite softness in dry dog food.

Nutrition has more complex economics. Infant nutrition, medical nutrition and premium supplements carry higher trust and scientific requirements, but they also bring more regulatory and execution risk. The 2026 infant-formula recall reduced RIG and margin, while the VMS write-down shows that a health-science label does not guarantee a moat. Nestlé's premium science-led nutrition assets can be attractive; commodity-like mainstream supplements have proven much less defensible.

Waters illustrates the weakest version of the model. S.Pellegrino and Perrier are valuable brands, but transporting heavy water, managing local springs and competing with low-priced alternatives produces structurally lower profitability. A 9–10% UTOP margin is respectable in isolation but far below Nestlé's coffee, PetCare or nutrition economics. The Peranel transaction improves portfolio quality even though it removes revenue.

Fixed versus variable cost is also category-specific. Ingredients, packaging, freight and retailer trade spending move substantially with volumes; factories, distribution infrastructure, R&D, much of administration and the baseline advertising system are less flexible. That creates moderate operating leverage. When volumes weaken after pricing, Nestlé does not simply remove advertising and innovation without damaging future demand. The 2022–24 experience is the warning: allowing marketing to fall too far made the subsequent growth repair more expensive.

Fuel for Growth is meant to change that equation by taking cost from procurement, administration, manufacturing and commercial systems rather than starving consumer-facing investment. The original 2024 program expected roughly three-quarters of savings from procurement, with the remainder from operational efficiencies and commercial investment. Procurement savings were expected to require relatively little implementation expense; operational-efficiency actions typically cost about twice their annual savings to execute.

At the aggregate level the industry is mature and defensive, but its subcategories have radically different growth economics. Mainstream packaged food competes against private label and retailer bargaining power. Premium coffee, pet nutrition, medical nutrition and convenient out-of-home products can grow structurally faster. Chocolate offers powerful branding but exposes manufacturers to cocoa spikes. Packaged food behaves as a consumer-demand business layered on top of a commodity cycle. Nestlé's H1 gross-margin pressure from coffee and cocoa, and Mondelēz's recent cocoa-driven pricing and margin volatility, show how quickly those cycles can reach reported earnings.

Comparisons with the closest peers are useful because each has solved a different version of the same problem.

Periods and margin definitions differ and should not be read as accounting-equivalent. The comparison is intended to show growth composition and broad economic position, not rank four margins mechanically.

Danone has become the cleaner European volume-recovery story. Its H1 2026 like-for-like growth was 3.5%, almost identical to Nestlé's, but 1.7 points came from volume/mix and 1.8 from price; its recurring operating margin rose to 13.3%. Danone's lower margin reflects a different portfolio, including dairy and specialized nutrition, but its current growth mix is slightly better balanced. It also has a clear 2025–28 ambition of 3–5% LFL growth with operating income growing faster than sales.

Unilever is now the more compelling benchmark for what genuine large-cap consumer volume momentum looks like. H1 2026 underlying sales growth was 4.8%, with 4.2% volume and just 0.6% price; Q2 volume reached 5.5%. Power Brands, representing 78% of turnover, grew 6.0%. Nestlé has better exposure to coffee and pet food, but Unilever's current growth composition places a much higher bar on claims that Nestlé has already completed its RIG repair.

Mondelēz is the most useful cocoa comparison. Q2 2026 organic revenue grew 2.2% and volume/mix 0.7%, after a period in which large chocolate price increases depressed volumes. Its adjusted gross margin recovered to 34.0% in Q2 as pricing and productivity offset part of raw-material pressure. That experience reinforces Nestlé's own disclosure that coffee price elasticity has been limited while confectionery elasticity has been much more pronounced.

General Mills represents the weaker end of the mature-food spectrum. Its fiscal-2026 outlook had called for organic sales contraction and a double-digit decline in adjusted profit before year-end performance improved sequentially; fiscal Q4 organic sales were approximately flat. Nestlé's portfolio therefore deserves better long-run economics than a conventional slow-growth U.S. food conglomerate, but that premium rests on actually producing volume growth from coffee, PetCare and nutrition rather than merely owning those categories.

The horizontal verdict is that Nestlé occupies the highest-diversification niche among these companies and owns arguably the best category portfolio, but it does not currently have the best execution. Unilever's volume performance and Danone's cleaner repositioning show that a large European staples group can produce stronger consumer-led growth. Mondelēz shows what commodity inflation can do to even powerful brands. General Mills shows the valuation and earnings risk when portfolio maturity becomes outright stagnation. Nestlé's moat is strong enough to keep it out of the last category; management still has to prove it can move closer to the first two.

Current fundamentals: RIG, China, restructuring, governance and portfolio

The central eight-quarter series is the cleanest test of the strategy:

† 2024 quarterly components are derived approximately from Nestlé's H1, nine-month, H2 and full-year disclosures; rounding means they should not be treated as company-reported standalone quarterly figures. From 2025 onward the quarterly figures shown are explicitly disclosed by Nestlé.

Evidence supports a real but incomplete volume recovery. RIG has been positive in five of the last six quarters and reached 1.8% in Q2 2026 while pricing fell below 2%. That is materially different from 2023, when organic growth was almost entirely a price story. The caveat is that Q2 2025 gives a warning about elasticity: a fast pricing move can still push RIG negative. Coffee has absorbed price increases unusually well; confectionery has not.

The current category cross-section strengthens the conclusion:

Waters produced Q2 RIG of 2.1% and pricing of 4.4%. Nutrition's turn from negative H1 RIG to positive Q2 RIG matters because the H1 number contained the infant-formula recall distortion. Coffee remains the standout: even after substantial price increases it has retained positive volume/mix. The recall deserves its own sentence rather than a margin adjustment. It began at the end of 2025 after Nestlé’s own testing at its Nunspeet plant in the Netherlands detected cereulide, a heat-stable toxin produced by Bacillus cereus, traced to a single supplier’s ARA oil, and widened through January 2026 across more than 50 countries and several infant-nutrition brands. What it tests is trust in a franchise whose entire premium rests on safety.

Geography is less comfortable. H1 developed-market RIG was just 0.6%. The Americas produced 1.0% H1 RIG and 0.8% in Q2; Europe produced 0.5% in H1 and zero in Q2. Zone AOA generated 2.8% H1 RIG and accelerated to 4.8% in Q2. Emerging markets excluding China delivered 7.1% organic growth and 3.9% RIG in H1. This is a powerful growth engine, but it also means the group-wide 1.8% Q2 RIG overstates what a developed-market consumer sees.

China deserves to be pulled out because the underlying demand signal is weaker than the improving headline. Greater China Q2 organic growth was 2.0%, split between 0.5% RIG and 1.5% pricing. Management said the trade-inventory reduction that began in Q2 2025 had been completed and described the business as stable, but it also said the categories in which Nestlé participates were still declining. In other words, channel inventory has normalized faster than end demand. A softer comparison base makes current reported growth look better before the category itself has turned. The starting point matters: Greater China organic growth was -10.6% in Q1 2026 with RIG of -10.4%, so the Q2 print is a rebound off a deeply negative base rather than a return to growth.

So I treat the “emerging markets excluding China” disclosure as analytically legitimate rather than cosmetic, while still regarding it as a warning. Removing China tells investors that India, Southeast Asia, Africa, Latin America and other emerging markets are genuinely strong. That the difference is so large simultaneously tells investors China remains material deterioration, not immaterial noise.

The other half of H1 is the earnings bridge. Nestlé's CHF 3.47 billion net profit can be reconciled exactly from UTOP as follows:

The bridge is mathematically complete: CHF 7,081 million less CHF 834 million, CHF 1,228 million, CHF 688 million and CHF 1,242 million, plus CHF 507 million from associates/JVs and less CHF 124 million of NCI equals CHF 3,472 million.

The CHF 834 million of net other trading expense contained CHF 469 million of restructuring, CHF 180 million of PP&E and intangible impairments, CHF 108 million for litigation and onerous contracts, CHF 93 million of miscellaneous trading expense, partly offset by CHF 16 million of other trading income. The CHF 469 million restructuring charge was allocated approximately CHF 178 million to coffee, CHF 67 million to PetCare, CHF 64 million to nutrition, CHF 140 million to Food & Snacks, CHF 7 million to Waters and CHF 13 million unallocated.

The CHF 180 million impairment within trading items comprised roughly CHF 144 million of PP&E impairment and CHF 36 million of intangible impairment. Separate from that, other operating expenses contained the much larger CHF 1.356 billion loss/write-down associated with businesses held for sale, plus a small CHF 1 million impairment of non-commercialized intangible assets. Other operating income included CHF 106 million of disposal gains and CHF 186 million of miscellaneous income; miscellaneous other operating expense was CHF 163 million. The result was net other operating expense of CHF 1.228 billion.

The accounting tax burden also rose because the held-for-sale write-down did not carry a full tax benefit. Nestlé's reported H1 tax rate was 28.7%, versus an underlying rate of 22.3%, with management explicitly citing limited tax deductibility of the write-down. Simply adding the CHF 1.3 billion charge back to net profit without considering taxes would therefore overstate normalized earnings.

Fuel for Growth is now large enough to influence every part of the P&L. Nestlé reported CHF 1.1 billion of cumulative savings for 2025 and CHF 1.7 billion by H1 2026, implying approximately CHF 0.6 billion of additional H1 2026 savings. The current interim target is CHF 2.0 billion during 2026 and the announced ambition is CHF 3.0 billion by end-2027.

The 16,000-role plan gives the program an unusually visible implementation cost. Around 12,000 white-collar roles are intended to produce approximately CHF 1.0 billion of annual savings by end-2027. Nestlé said one-off restructuring costs for that tranche should be around twice annual savings, implying roughly CHF 2 billion of implementation expense over the program. Another roughly 4,000 jobs are expected to leave through manufacturing and supply-chain productivity actions; Nestlé has not disclosed an equally precise all-in cash-cost budget for that tranche. The CHF 469 million H1 restructuring charge cannot be read as the whole cash cost of the program, nor does a P&L provision tell investors exactly when cash leaves the company.

On reinvestment, the directional answer is clearer than the precise accounting one. Advertising and marketing was 8.1% of sales in 2024, 8.6% in 2025 and 8.9% in H1 2026. On H1 sales of CHF 43.1 billion, the 30-basis-point year-on-year increase alone corresponds to roughly CHF 130 million of additional spending measured as a share of sales. Yet despite about CHF 600 million of incremental savings in H1, UTOP margin was 16.4%, ten basis points below the prior-year period. Coffee and cocoa inputs, tariffs, FX and the formula recall absorbed part of the remainder. Nestlé does not publish a CHF-for-CHF split saying exactly how much Fuel for Growth goes to brand reinvestment versus margin; any analyst claiming one would be inferring beyond the disclosure.

This explains management's H2 guidance. If H2 UTOP margin is broadly similar to H1, full-year margin should improve from 2025's 16.1% but remain well below the 17%+ medium-term ambition. Cost savings are currently funding the repair more than they are dropping straight to shareholders. That is appropriate while market share is being rebuilt, but it limits near-term earnings leverage.

Portfolio actions are now best tracked by legal status rather than headline value.

The Waters deal is agreed and announced, subject to consultation and regulatory approvals, with H1 2027 closing targeted. There has been no closing and no cash receipt as of September 5, 2026. Nestlé expects around CHF 2.8 billion of cash at closing while retaining 50% of Peranel. Once control is lost, Waters revenue and UTOP will disappear from consolidated sales and operating profit and Nestlé will recognize its retained stake through equity accounting. The H1 financial statements also identify approximately CHF 1.3 billion of cumulative currency-translation losses associated with Waters that would be recycled through the income statement when control is lost; this would be largely non-cash but could make reported profit look ugly again. Not everything leaves with the revenue. The contingencies note in that same half-year report states that operating practices at some of Nestlé’s natural mineral water production sites may not be in line with the applicable regulatory framework, that no material provision has been recognized, and that potential future liabilities cannot be quantified. Retaining 50% of Peranel means the exposure is shared rather than removed.

The mainstream/value VMS transaction is one step earlier in economic realization but similar legally: an agreement was reached September 1 for about CHF 0.8 billion, closing is expected by H1 2027, and cash has not yet been received. It removes approximately CHF 1.0 billion of 2025 revenue but leaves Nestlé with higher-end science-led supplement brands. Nestlé also moved its remaining ice cream business, roughly CHF 1 billion of sales destined for the Froneri joint venture, into assets held for sale during H1 2026. The half-year report treats it as a non-significant disposal group, so it does not change the attribution of the CHF 1.356 billion write-down.

Blue Bottle was divested during H1 2026. Nestlé also completed the purchase of the remaining 51% of yfood in early July; yfood generated around €150 million of 2025 sales. These are smaller transactions, but together with Waters and VMS they show that capital allocation has become more explicitly category-selective.

The balance-sheet objective should be judged after the 2027 closings. Cash proceeds of approximately CHF 3.6 billion from Waters and VMS would materially help leverage, but they do not create free value: Nestlé gives up consolidated earnings streams at the same time. The correct test is whether lower debt plus the retained Peranel stake and a cleaner mix earn a higher return on capital than retaining those businesses wholly owned.

Governance has changed operating cadence in three observable ways. Management now reports much more explicitly on RIG, underperforming cells and growth platforms; cost savings carry headcount and recurring-savings targets; and portfolio reviews are producing signed exits instead of open-ended strategic language. The board has also altered oversight practices. What has not yet changed is the evidence window: Navratil has only one full year of quarterly execution behind him, and Isla has been chairman for less than a year at this research date. The management reset deserves analytical credit for actions, not yet a credibility premium for outcomes.

Valuation, risk, catalysts and tracking

Valuation starts with cash, not earnings multiples.

Across 2021–25, operating cash flow has exceeded cumulative accounting net income in my reconstruction by roughly 30%. The main distortion is that reported earnings contain items such as the 2021 L'Oréal transaction, restructuring, impairments and asset-disposal effects that do not line up neatly with recurring operating cash. Nestlé remains a strong cash converter, although 2025 FCF fell to CHF 9.2 billion from CHF 10.7 billion in 2024 as margins and working capital normalized.

Nestlé does not disclose maintenance capex separately from growth capex. I therefore estimate it rather than pretend it is observable. A reasonable normalized assumption is that roughly 65–75% of physical capital expenditure is maintenance, anchored around depreciation/replacement needs, with the remainder supporting capacity, digitalization and growth projects. On that basis, normalized owner earnings before the L'Oréal dividend contribution are roughly CHF 10.5–12.3 billion across my conservative-to-optimistic cases. The estimate is deliberately wider than an accounting EPS forecast because the maintenance/growth split is a research assumption, not a management KPI.

At the current CHF 78.31, 2025 reported EPS of CHF 3.51 gives a headline P/E of about 22.3 times. My normalized owner-earnings framework produces a materially lower effective multiple, around the mid-teens depending on maintenance capex and working-capital normalization. The discrepancy reinforces the reason to use both owner earnings and operating EV rather than a single group P/E.

The mandatory SOTP is as follows. Nestlé owns approximately 20.16% of L'Oréal. I use the September 4 L'Oréal close of €383.90 and EUR/CHF 0.9401, giving CHF 38.84 billion gross. I apply a 10% total valuation haircut: 5% is an explicit reserve for tax/leakage because the public filings do not disclose a tax basis and legal selling structure sufficient to calculate an exact realized tax bill; a further 5% is a strategic-realization/friction discount for monetizing a block of this size. I do not apply a separate conventional “minority-control discount”: the quoted L'Oréal share price already represents the market value of a minority share. The resulting SOTP value is CHF 34.96 billion, or about CHF 13.6 per Nestlé share.

This stake alone represents about 19% of Nestlé's roughly CHF 200 billion equity value before the haircut and about 17% after it. Hence a consolidated Nestlé P/E is a poor primary valuation tool.

On the operating side, using about CHF 201.5 billion of analytical equity value at the current quote, CHF 56.3 billion of H1 net debt and CHF 35.0 billion for the discounted L'Oréal stake gives roughly CHF 223 billion of implied enterprise value for the consolidated Nestlé operations. Against approximately CHF 14.5 billion of normalized 2026 UTOP, the market is paying roughly 15–16 times operating profit. The exact figure moves with year-end debt, disposal proceeds and H2 margin; it is a valuation anchor, not an accounting multiple published by Nestlé.

Peer operating data do not justify paying Nestlé an unquestioned premium. Danone is producing similar sales growth with a slightly better volume mix; Unilever is currently producing much stronger volume growth; Mondelēz has lower volume but faces the cleanest cocoa comparison; General Mills has weaker growth economics. Nestlé deserves a quality premium over low-growth mainstream food, but the current evidence does not justify a premium for execution over Unilever or Danone.

I do not attach a precise “historical percentile” to the current Nestlé multiple because a clean multi-decade primary-source series that consistently removes the changing L'Oréal stake and uses the same earnings definition is unavailable. The observed capital-market history is sufficient to say that Nestlé has de-rated substantially from its 2021–22 defensive premium, but at 15–16 times normalized operating profit after stripping out L'Oréal it is not priced like a distressed staples company.

The absolute scenario valuation is deliberately built from both operating-profit and owner-earnings logic:

† Returns assume the midpoint of each fair-value range as three-year terminal value plus roughly three years of dividends; they are scenario mathematics rather than expected market forecasts.

The conservative case assumes RIG slows after the current emerging-market rebound, developed-market growth remains weak, UTOP margin stays around the mid-16s or slightly below, and the market values the operating business at only a modest quality premium to mature food. The base case assumes RIG settles around 1.5–2.0% or better, pricing normalizes, savings fund both investment and some margin repair, disposals close broadly on schedule, and leverage trends down. The optimistic case requires a clear return toward Nestlé's medium-term 4%+ organic-growth and 17%+ margin architecture, plus better China and developed-market volume performance.

At today's price the expectation gap is narrow. The market no longer prices a broken Nestlé: the operating business already carries a mid-teens UTOP multiple. It also does not price a completed turnaround: CHF 78.31 is below my base-value midpoint and far below a 17%+ margin/4%+ growth success case. The most important next variable is not another CHF 100 million of restructuring savings but whether Q3 RIG remains at or above roughly 1.5% as coffee pricing annualizes and whether Europe and the Americas improve.

Nine-month sales on October 22, 2026 are the next scheduled financial release. Because Nestlé reports sales rather than full financial statements at nine months, the market's most useful data will be Q3 RIG/pricing by zone and category, China, market-share commentary and progress toward the CHF 2.0 billion 2026 cumulative savings target. The full-year results are scheduled for February 18, 2027.

The independent margin-of-safety test is less generous than the base-case valuation. Current price is above the CHF 68–73 conservative fair-value range; under the user's required discipline, the margin of safety to the conservative case is therefore zero. The most fragile base assumption is the continued mid-teens operating multiple. If the 15.5× multiple is cut mechanically to 70%, about 10.85×, while the other base inputs remain unchanged, the SOTP falls to roughly the low-to-mid CHF 50s per share. Multiple compression can undo operational progress quickly.

The “flat earnings for three years” test is more benign. Holding the share price flat and assuming the CHF 3.10 annual dividend is maintained gives a gross cash return of about 4.0% a year before taxes. That is above Swiss Confederation long-bond yields around the base date, but it remains an income return with no growth and does not create a discount to conservative intrinsic value.

Margin-of-safety sufficiency verdict: none.

Permanent-loss risks are concentrated rather than numerous.

The first is a false RIG recovery. Probability is medium and impact high. The observable indicator is group RIG falling below 1% again, especially if developed-market RIG turns negative while emerging ex-China growth slows. The transmission path is direct: lower volume spreads fixed manufacturing and marketing costs over fewer units, forces additional price/promotion support, prevents margin normalization and convinces the market that the 2026 recovery came from easy comparisons. That can hit earnings and the multiple simultaneously.

The second is permanent loss of category share in developed markets. Probability is medium and impact high. Europe delivered zero Q2 RIG and the Americas only 0.8%, while Unilever delivered 5.5% Q2 volume growth across its own consumer portfolio. Nestlé does not need to match Unilever mechanically, but persistent sub-1% developed-market RIG would indicate that stronger advertising and innovation are not translating into consumer pull.

The third is restructuring that costs more than it earns. Probability is medium and impact medium-to-high. White-collar restructuring alone carries an indicative one-off cost of around twice the CHF 1 billion annual saving target. If cumulative charges approach several billion francs while UTOP stays around 16%, shareholders will have paid for a leaner organization without receiving a higher return on sales. The observable indicators are annual restructuring cash charges, savings realization, A&P reinvestment and UTOP margin.

The fourth is capital-allocation repetition. Probability is low-to-medium but impact high. Bountiful is the current evidence: a USD 5.75 billion acquisition followed several years later by a material write-down and disposal of mainstream assets. The risk is not the accounting loss already taken; it is using future disposal proceeds to make another expensive “strategic” acquisition before leverage and operating execution are repaired.

The fifth is balance-sheet stagnation. Probability is low-to-medium and impact medium. Net debt/adjusted EBITDA reached 2.9 times in 2024, near the top of the 2–3 times range. If 2027 disposals close but leverage remains above 3 times because FCF weakens, restructuring consumes cash or another acquisition intervenes, the market can no longer treat Nestlé's dividend and defensive balance sheet as near-riskless.

The sixth is China becoming structural rather than cyclical. Probability is medium and impact medium. The channel inventory correction is complete, yet the participating categories remain in decline. A further year of negative category demand would reduce the probability that China returns to being a meaningful RIG contributor and could force additional portfolio or route-to-market changes.

The seventh is legal and regulatory exposure attached to Waters. Probability is medium and impact medium. The contingencies note described above is unquantified by Nestlé’s own account, and the 50% retained stake in Peranel means an adverse outcome would not be fully transferred out with the disposal. The observable indicator is any provision appearing against this item in a future disclosure.

Positive catalysts over the next year are concrete: Q3/Q4 RIG staying around 1.5–2% despite lower pricing; Europe moving from zero to positive RIG; continued coffee volume resilience; FY UTOP margin above 16.1% with A&P near 9%; FCF above CHF 9 billion; and Waters/VMS approvals progressing toward H1 2027 closes. Those would turn the current cost-and-governance reset into evidence of a durable operating turnaround.

Negative catalysts are equally measurable: a Q3 RIG relapse, China slipping back into negative RIG after the comparison benefit passes, another major impairment, FY FCF below guidance, Waters/VMS delay, or restructuring costs rising without margin improvement. Coffee is particularly important: the current case assumes that the category can annualize high pricing without the volume elasticity seen in chocolate.

These operating indicators should be read together. A falling advertising ratio accompanied by better RIG could indicate efficiency; a falling ratio accompanied by weaker RIG would raise the old underinvestment problem again. Likewise, savings above target are valuable only if they either increase consumer investment or show up in margin and cash.

Cross-synthesis, rating, uncertainties and sources

Vertically, the capability Nestlé has genuinely proven runs deeper than “brand building.” It is the ability to take food technologies or acquired consumer franchises, industrialize them, distribute them globally and preserve their relevance for decades. Nescafé, Maggi, Nespresso and Purina arrived through different routes and different eras, yet each became larger because Nestlé could pair product with global distribution. The Ralston Purina transaction is the clearest proof that the system can create enormous value when category quality, purchase economics and integration all align.

Past success was helped by its era. Rising global incomes, modern retail, urbanization, women's labor-force participation, convenient packaged food and globalization all expanded the addressable market. Low interest rates later supported high defensive-equity multiples. But those tailwinds do not explain why Purina earns a category margin above 20% or why coffee can absorb large price increases while still growing RIG. Those are franchise characteristics. The problem since 2022 has been extracting the full value of them consistently.

Treating breadth as an advantage regardless of the quality of each business was the deepest strategic mistake of the last cycle. Nestlé's portfolio contained categories with very different economics while group resources became too thinly spread. The fall in advertising and marketing from 9% of sales in 2019 to 6.6% in H2 2022 is a numerical sign of that dilution. Management then discovered that 18 business cells accounting for 21% of sales were responsible for most share losses. A company can own globally famous brands and still underinvest in the local price, pack, shelf and advertising decisions that determine whether consumers buy them.

Navratil's strategic contribution so far is to make that trade-off harder to avoid. A CHF 3 billion savings program, 16,000 planned role reductions, more aggressive disposal work and explicit RIG targets make resource allocation observable. This is better than broad transformation language because shareholders can measure whether savings appear and whether RIG follows.

Governance is a more nuanced story. Dismissing Freixe for a clear Code violation was the right board response once the investigation established the facts. It was nevertheless a governance failure that the situation arose at all, and it followed another CEO transition barely a year earlier. Accelerating Bulcke's departure and strengthening board procedures reduced the perception that continuity at the top mattered more than accountability. Isla's record gives the board an experienced external operator, but the relevant measure will be whether Nestlé now changes CEOs less often because succession, incentives and oversight improve.

Horizontally, Nestlé owns a better collection of categories than its current execution suggests. Coffee and PetCare are structurally more attractive than much of traditional grocery. Nutrition can be attractive when scientific differentiation is genuine. This should let Nestlé grow somewhat faster and earn better returns than the weakest U.S. packaged-food peers.

The catch is that Unilever and Danone currently show what better execution looks like. Unilever's H1 2026 growth was overwhelmingly volume-led; Danone produced a balanced price/volume mix and margin expansion. Nestlé's Q2 group RIG of 1.8% is meaningful progress but is still supported heavily by emerging markets, while Europe produced zero RIG. A quality premium should be paid for evidence, not brand names inherited from earlier decades.

China is probably the market variable most susceptible to misreading. The inventory correction is over, and that is genuine improvement. It removes a self-inflicted drag and lets reported sales track end demand more accurately. The end demand itself remains weak. Management's statement that the relevant categories are still declining makes it too early to call a Chinese recovery.

At the group level, however, I think the volume recovery is real. The evidence is stronger than one quarter: RIG recovered in Q3 2025, stayed positive in Q4 and Q1 2026, and rose to 1.8% in Q2 while pricing moderated. Coffee has maintained positive volume through price increases. PetCare is positive. Nutrition returned to positive Q2 RIG. The remaining weakness is breadth, not existence.

That distinction determines the one-year investment debate. The 3–4% 2026 organic-growth guidance is achievable with roughly 1.5–2% RIG plus 1.5–2% pricing. H1 already delivered 3.6% organic growth on 1.5% RIG and 2.1% price. The harder part is the margin: savings are being absorbed by commodity costs, tariffs, recalls, advertising and restructuring. A 17%+ margin is a medium-term destination, not a sensible 2026 assumption.

For the three-year horizon, portfolio quality matters more. A Nestlé without full consolidation of Waters and mainstream VMS will report less revenue, but the retained mix should carry higher margins and higher returns. That is preferable if the sales are genuinely lower quality. The danger is confusing disposals with growth: selling CHF 4–5 billion of annualized revenue does not improve organic demand. The remaining company still has to grow.

For the five-year horizon, the test is whether the company can restore a durable model of roughly 4% organic growth with at least 17% UTOP margin and stronger capital discipline. If it can, Nestlé resumes looking like a compounder. If organic growth settles at 2–3%, cost savings merely prevent margin erosion and another expensive acquisition absorbs the balance-sheet capacity created by disposals, the stock becomes a mature high-dividend cash cow deserving a much lower multiple.

L'Oréal complicates both outcomes. The stake is a first-rate asset and provides meaningful equity value, but it can disguise the valuation of the food business. At the current mark, I attribute approximately CHF 13.6 per Nestlé share to L'Oréal after my 10% haircut. An investor paying CHF 78.31 is paying roughly CHF 64–65 for the rest of the equity after that asset, before considering how debt is allocated. On an enterprise-value basis, the operating company still commands about a 15–16× normalized UTOP multiple. That is not a distressed price.

Most likely the market is misjudging two things in opposite directions. Bears can underestimate how much latent earnings power exists if Nestlé stops losing share while procurement savings and brand investment compound together. Bulls can underestimate the amount of those savings required simply to repair prior underinvestment and absorb input inflation. H1 2026 illustrates both at once: CHF 600 million of incremental savings, more A&P and better RIG, yet UTOP margin was still slightly lower year on year.

Valuation has to separate “business getting better” from “stock cheap.” The business is getting better. The current price does not offer a discount to my conservative value.

Bull reasons

• Group RIG reached 1.8% in Q2 2026 while pricing moderated to 1.9%, the clearest evidence in several years that organic growth is shifting back toward volume/mix.
• Emerging markets excluding China generated 7.1% H1 organic growth and 3.9% RIG, providing a strong growth engine outside mature Western markets.
• Fuel for Growth reached CHF 1.7 billion of cumulative savings by H1 and carries a CHF 3 billion end-2027 ambition, creating substantial capacity to fund both A&P and margin repair.
• L'Oréal contributes about CHF 35 billion to my after-haircut SOTP, while coffee and PetCare retain category operating margins around 19–22%, giving the group unusually strong asset backing and franchise economics.

Bear reasons

• Developed-market H1 RIG was only 0.6%, with Europe at zero in Q2, so the group RIG recovery remains concentrated geographically.
• China inventory correction is complete but the categories Nestlé participates in are still declining, which weakens the argument that the current Chinese improvement is a demand recovery.
• H1 net profit fell 31.4%, with CHF 469 million of restructuring and a CHF 1.356 billion held-for-sale loss/write-down showing that portfolio repair carries real economic and accounting cost.
• After stripping out L'Oréal, the operating company still trades around 15–16× normalized UTOP, leaving no discount to the conservative valuation if RIG or margin improvement stalls.

Pre-mortem

The first concrete three-year failure script begins in 2027. Coffee pricing annualizes, European RIG stays around zero, North American PetCare loses share to Mars/Royal Canin and premium private-label alternatives, and China's nutrition categories continue to contract. Group RIG slips from 1.8% toward 0–0.5%. Management keeps advertising near 9% because cutting it would worsen share loss, so the CHF 3 billion savings program mostly offsets weaker volumes and input costs. UTOP falls toward CHF 12 billion and margin settles around 14–15% instead of returning above 17%. The market cuts the operating multiple from roughly 15.5× to 11–12×; if L'Oréal simultaneously falls around 20% and net debt remains above CHF 50 billion, Nestlé equity can fall into the CHF 40 area, roughly half the September 2026 price.

The second script is capital allocation rather than consumer demand. Waters and VMS close, Nestlé receives the expected cash, leverage approaches the desired midpoint, and management interprets the restored balance sheet as permission for another large premium-priced health/nutrition acquisition. Integration then repeats the Bountiful pattern: supply problems, a goodwill impairment and weak FCF. The dividend absorbs roughly CHF 8 billion a year, FCF falls below CHF 8 billion, leverage returns above three times EBITDA and investors withdraw the defensive-quality premium. A low-teens operating multiple combined with no earnings growth can again produce a 40–50% permanent impairment even without a recession. The Bountiful experience makes this script less theoretical than it would be for a company with a spotless acquisition record.

The final research conclusion is that Nestlé remains a high-quality collection of consumer assets inside a company whose corporate execution is still being repaired. The new regime has earned credit for measurable actions: RIG is improving, underperformers are receiving focused capital, the savings program is larger and more concrete, and portfolio decisions have moved from review to signed transactions. Coffee and Purina remain franchises I would be comfortable capitalizing at a quality multiple. The L'Oréal holding adds roughly CHF 35 billion of separately observable value after a deliberately conservative haircut.

At CHF 78.31, however, the stock already gives the operating company credit for a meaningful part of the repair. My base valuation is around the low-CHF80s; the conservative range is CHF 68–73. The present quote therefore offers reasonable value to an existing holder who wants defensive cash flows and is prepared to wait for execution, but it gives new capital no conservative margin of safety. A much better setup would combine a price in the mid-to-high CHF50s with RIG still at least around 1.5%, UTOP margin remaining above 16%, and no deterioration in leverage. A falling share price caused by a collapsing RIG trend would not meet that condition.

【Company-profile scores】

• Fundamental quality: high
• Growth: medium
• Moat: strong
• Financial soundness: medium
• Management credibility: medium
• Valuation attractiveness: low
• Risk level: medium
• Suitable investor type: dividend

【Investment rating】

• Rating: Hold
• One-line thesis: RIG is recovering and portfolio discipline is improving, but CHF 78.31 already prices a mid-teens operating multiple with no conservative margin of safety.
• Acceptable hold price: 72–92 CHF
• Clearly overvalued price: 105–110 CHF
• Current-price classification: acceptable hold
• Whether to wait for a better price: yes; for new capital I would require approximately CHF 58 or below while RIG remains around 1.5%+ and UTOP margin stays above 16%. The main opportunity cost is the roughly 4% gross dividend yield foregone while waiting.
• Target holding horizon: 3–5 years
• Expected annualized return: conservative approximately 0.6%; base approximately 5.3%; optimistic approximately 10.7% over three years, including assumed dividends.
• Max-loss risk: roughly 45–50% in the pre-mortem case where RIG returns toward zero, UTOP falls toward CHF 12 billion, the operating multiple compresses to 11–12×, leverage remains elevated and L'Oréal falls materially.
• Reassessment-trigger signals: group RIG below 0.5–1.0% for two consecutive quarters; UTOP margin below 16% on two consecutive half-year readings; FY FCF below CHF 8 billion; net debt/adjusted EBITDA still above 3× after the planned 2027 disposal proceeds; China RIG below zero after the inventory-reset comparisons have normalized.

【Ideal Buy Price】54–58 CHF

Basis: my conservative SOTP/owner-earnings cross-check is approximately CHF 68–73 per share; CHF 54–58 represents roughly a 20% or greater discount to that conservative value while separately marking the L'Oréal stake.

【Valuation Range】

• current: 78.31 CHF (close as of 2026-09-04)
• bear (conservative · ideal buy zone): [54, 58]
• base (fair · acceptable hold zone): [72, 92]
• bull (optimistic · above the clearly-overvalued line): [105, 110]

This is valuation-scenario analysis within a research framework, not investment advice.

Research uncertainties. Four blind spots matter. First, Nestlé does not disclose maintenance versus growth capex, so owner earnings require an explicit estimate. Second, the tax basis and exact selling structure of the L'Oréal stake are not public enough to calculate a statutory disposal tax; my 5% tax/leakage reserve is a valuation convention, not a forecast tax bill. Third, the 2026 segment architecture differs from earlier reporting, preventing a perfectly like-for-like eight-quarter category/zone matrix without analyst reconstruction; the group-level quarterly RIG series is more reliable. Fourth, the named internal Research Hub reports on Danone, Unilever, L'Oréal and other peers were not exposed as searchable resources in this conversation, so peer conclusions here were rebuilt independently from issuer disclosures rather than inheriting the library's ratings or valuation ranges.

Source hierarchy. The analysis gives priority to Nestlé's H1 2026 release and financial statements, 2025 annual/full-year materials, 2024 annual results, quarterly sales releases, governance announcements, transaction releases and investor-calendar disclosures. The H1 primary materials support the growth, margin, cash-flow, impairment and segment analysis. The CEO and chairman conclusions come from Nestlé's own board announcements and AGM/governance material. Portfolio conclusions are grounded in Nestlé's transaction announcements for Peranel, VMS and the historical Bountiful acquisition. Peer operating comparisons use Danone, Unilever, Mondelēz and General Mills primary releases. Current NESN price is verified against the September 4 close, while the L'Oréal SOTP uses L'Oréal's dated share-price disclosure and contemporaneous CHF conversion.

Other tickers mentioned

OR.PA: separately valued listed associate behind roughly CHF 35 billion of Nestlé SOTP value after the applied haircut.

BN.PA: closest European food and specialized-nutrition comparison, with a cleaner current volume/mix recovery.

ULVR.LSE: large-cap European consumer restructuring comparison with substantially stronger H1 2026 volume growth.

MDLZ.US: global snacks and confectionery comparator illustrating cocoa-pricing elasticity and margin pressure.

GIS.US: mature U.S. packaged-food comparator framing the weaker-growth end of the sector.

This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.